As covid-19 devastated communities across the nation in spring 2020, a group of Black ministers in this racially divided city made an urgent plea for more testing in their neighborhoods.
FDA grants full approval to Leqembi, opening up coverage of Alzheimer’s drug by Medicare
For the first time in 20 years, the FDA has bestowed full approval on a drug to treat Alzheimer’s disease, opening the door to coverage
July 7, 2023